Start personalised prostate cancer prevention today

AntePC

Take charge of your prostate cancer risk with personalised prevention. Through advanced genetic analysis, we provide a tailored screening and prevention plan designed specifically for you. Even without a family history of cancer, genetic risk assessment can offer early insights to help you stay proactive about your health.

Discover your genetic risk level for prostate cancer
Get personalised medical guidance on when to start screening and how often
Learn actionable steps to reduce your risk
Powered by clinical-grade genetic testing with a saliva collection kit delivered to your door
Access your clinical recommendations online within 6 weeks
Recommended for men aged 40 and above

Important information

E-mail *

Test results are connected to the e-mail you provide.

Product price:	£ 299.00
Additional options total:
Order total:

Changemakers

1 in 3 men are diagnosed with cancer in their lifetime. Early prevention is crucial.

The current prostate cancer reality

1 in 7

Prostate cancer is the most common cancer in men, affecting 1 in 7 men in their lifetime.
55 000

Did you know that more than 55 000 new cases of the disease are diagnosed in the UK every year, and around 12 000 men die from prostate cancer each year. Early prevention is crucial.
30%

The five-year survival rate for early prostate cancer patients is nearly 100%. But only about 30% of patients with advanced prostate cancer survive five years or longer.

Next-generation prevention

Personalised prostate cancer prevention with genetic risk assessment can give early warning to men at risk even if there is no cancer in the family. Moreover, it guides you towards tailored screening and prevention based on personal risk levels.

More than just genetic testing. Here's what you'll learn:

View sample report

What is my genetic risk level of prostate cancer
At what age should you start prostate cancer screening, and how often
Are there additional measures you can take to lower your risk
What proactive measures can you adopt to reduce your likelihood of developing prostate cancer
What changes and symptoms should you monitor regarding prostate cancer
What should your doctor know

Prevent prostate cancer based on your unique risk profile

Prostate cancer and related deaths can often be prevented through timely measures, even before symptoms develop.
Each man’s risk of developing prostate cancer is highly individual. For those at high genetic risk, the likelihood of developing breast cancer can already be significant in their 30s and 40s. This should be carefully considered when planning screenings.
Your prevention plan is fully personalised by considering your genetic makeup, age, sex, and ethnicity.

Health-conscious men aged 40 and above – Looking for science-backed prevention strategies.
Especially beneficial for men under 50 – To identify those at higher risk early.
Those with or without a family history – Genetic risk can be significant even without familial cases that make up only 20% of current cases.

Many cancers result from a combination of multiple genetic factors, making them polygenic. Polygenic Risk Score (PRS) is a measure of disease risk based on analysis of multiple genetic variants associated with the disease. Polygenic risk can be significant even without a family history of cancer.
The Antegenes PRS technology calculates the combined effect of 121 genetic variants associated with prostate cancer, generating a risk score for developing the condition.
By combining the PRS with your background (ethnicity, age and sex), we provide accurate risk assessments and tailored medical advice to prevent illness or promote early detection.

Personalised prostate cancer prevention includes:

Saliva-based genetic risk test for prostate cancer;
Combined effect analysis of 121 genetic variants associated with prostate cancer across the genome;
Your polygenic risk score for prostate cancer;
Prostate cancer risk compared to the general male population in your country;
Probability of developing the condition within 10 years;
Interpretation of test results with clinical recommendations for prevention and screening with clear steps on what you should do next;
Hereditary cancer questionnaire to assess additional monogenic risk factors;
The test report includes additional comprehensive clinical guidelines for your local healthcare professionals, guiding the next possible medical steps for personalised prostate cancer prevention.
With scientifically backed and well-documented medical advice, the information you receive may support access to further testing or follow-up care within your local healthcare system, whether public or private, helping you take proactive steps to protect your health.
If you have any questions regarding your results, we offer optional post-test consultations and support for patients seeking personalised medical guidance.

Start today

How it works

1 Order your kit
Order your kit online by filling in the form below.
2 Provide a sample at home
Provide a sample using a simple saliva spit collection kit and use the prepaid envelope to return your sample.
3 Complete the questionnaire
Complete the family history questionnaire on our patient portal to assess additional monogenic risk factors for hereditary prostate cancer.
4 Receive your results
You can access your results within 6 weeks online accompanied by medical recommendations that guide your next steps.

Approved by doctors and men

What people say

"As a result of the Antegenes genetic test, I know that my risk of prostate cancer is elevated, and the test report provided solid medical guidance on how to routinely check my health. This knowledge gave me the conviction that I have to check my health earlier and regularly. Before any complaints appear."

Andres, 46
"It's convenient to collect the sample at home at a suitable time. The description of the results is comprehensive, the recommendations are understandable, and they are available for later reference. All in all, the Antegenes genetic risk testing gave me peace of mind."

Alar, 43
"For me, the greatest value is the information that I need to undergo cancer screening much earlier than the national plan suggests. The body awareness instructions provided by Antegenes are clear and easy to understand, helping me to transform my daily habits. I now also know which signs and changes I need to pay attention to."

Mark, 44

We’re here to answer your questions

What does personalised prostate cancer prevention include?
Personalised prostate cancer prevention includes:
- Saliva-based genetic risk test for prostate cancer;
- Combined effect analysis of 121 genetic variants associated with prostate cancer across the genome;
- Your polygenic risk score for prostate cancer;
- Prostate cancer risk compared to the general male population in your country;
- Probability of developing the condition within 10 years;
- Interpretation of test results with clinical recommendations for prevention and screening with clear steps on what you should do next;
- Hereditary cancer questionnaire to assess additional monogenic risk factors;
- The test report includes additional comprehensive clinical guidelines for your local healthcare professionals, guiding the next possible medical steps for personalised prostate cancer prevention.
- With scientifically backed and well-documented medical advice, the information you receive may support access to further testing or follow-up care within your local healthcare system, whether public or private, helping you take proactive steps to protect your health.
- In case you have questions regarding your results, we also provide optional post-test consultations and support for patients seeking personalised medical guidance.
AntePC Test Limitations
- AntePC test is not used to diagnose prostate cancer.
- An elevated risk estimated by the AntePC test does not mean that you will develop prostate cancer during your lifetime. Also, a moderate or lower risk does not mean that the probability of developing the diseases is zero.
- AntePC test does not assess the risk of your family and relatives, i.e. polygenic risk score-based disease risks may not be transmitted directly from parents to children.
- AntePC test does not analyze rare pathogenic mutations in genes that significantly increase the risk of prostate cancer, such as BRCA1, BRCA2, ATM, CHEK2, EPCAM, HOXB13, MLH1, MSH2, MSH6 and others.
- The AntePC test is based on the most up-to-date scientific data, which may, however, be supplemented and changed in the future as additional information becomes available. The field of genetics is constantly evolving, which may lead to changes in risk assessments over time, as well as changes in test selection recommendations and clinical recommendations based on test results.
- Different polygenic risk scores predicting risks of the same trait may give different estimates of the individual’s risks due to differences in the genetic variants included in the models and their weights.
- The results of this test should be applied in context with other relevant clinical data. In addition to the possible genetic predisposition, other risk factors also influence the risk of prostate cancer.

Fully compliant with all regulatory bodies

Personalised cancer prevention is based on genetic risk tests provided by Antegenes.

✔ CE-marked medical devices (in vitro diagnostics, IVD)
✔ Registered in the UK MHRA Registry and EUDAMED database
✔ Developed using anonymised data from the UK Biobank
✔ Antegenes is ISO 13485 certified
✔ We take your data privacy and protection very seriously